Author: Tom Wilemon
Black patients with cancer face worse COVID outcomes: study
Mar. 31, 2022—Vanderbilt researchers have found that Black patients with cancer experienced significantly worse outcomes after COVID-19 diagnosis than non-Hispanic white cancer patients.
Berlin named interim leader of Hematology and Oncology
Mar. 24, 2022—Jordan Berlin, MD, has been appointed interim leader of Vanderbilt's Division of Hematology and Oncology in the Department of Medicine.
VUMC’s Pietenpol, Shyr named AACR Fellows
Mar. 22, 2022—Vanderbilt's Jennifer Pietenpol, PhD, and Yu Shyr, PhD, have been inducted as fellows of the American Association for Cancer Research Academy.
Ferrell lands Mark Foundation for Cancer Research award
Mar. 17, 2022—Vanderbilt's Brent Ferrell, MD, is one of the recipients a 2022 Endeavor Award from the The Mark Foundation for Cancer Research.
Martin shares colorectal cancer story, urges early detection
Mar. 9, 2022—Vanderbilt Wilson County Hospital's Lori Martin uses her own experiences to educate patients about the importance of early detection of colorectal cancer.
Study finds World Trade Center responders at higher risk for blood cancer-associated mutations
Mar. 7, 2022—A study by Vanderbilt and New York City researchers found that 9/11 first responders to the World Trade Center have increased levels of mutations that escalate their risk for blood cancers or cardiovascular disease
Grant to support Haake’s research on kidney cancer
Feb. 17, 2022—Kure It Cancer Research has awarded a $200,000 grant to support kidney cancer research by Vanderbilt's Scott Haake, MD.
Osterman plays key role in major oncology EHR initiative
Feb. 3, 2022—Vanderbilt's Travis Osterman, DO, MS, is leading an integral component of the Minimal Common Data Elements (mCODE) initiative, establishing common data standards for oncology clinicians and researchers.
New fund supports appendiceal cancer research
Jan. 27, 2022— by Tom Wilemon The newly established Dalton Family Foundation Appendix Cancer Research Fund will support investigations by the Division of Epidemiology at Vanderbilt University Medical Center to better understand this rare malignancy. An initial grant from the Dalton Family Foundation will fund the work of Andreana Holowatyj, PhD, MSCI, assistant professor of Medicine, and...
Comprehensive framework outlined for addressing early-onset colorectal cancer research
Jan. 25, 2022—New research from Vanderbilt sets a comprehensive framework for addressing research challenges and patient needs for people under 50 with colorectal cancer.
Clinical score can guide PRRT therapy decisions for neuroendocrine tumors
Jan. 19, 2022—A clinical score system developed by researchers at Vanderbilt-Ingram Cancer Center (VICC) has been validated that can guide peptide receptor radionuclide therapy treatment decisions.
Vanderbilt biostatisticians launch Cancer-Immu data portal for predicting response to immune checkpoint blockade immunotherapy
Jan. 14, 2022—A new data portal called Cancer-Immu established by a team of Vanderbilt University Medical Center biostatisticians can help cancer clinicians and researchers predict which patients will respond to immune checkpoint inhibitors.